Skip to main content

Table 3 Number of respondents who report being advised about possible risks of PSA testing

From: Prostate specific antigen testing in family practice: a cross sectional survey of self-reported rates of and reasons for testing participation and risk disclosure

Received advice about potential risk (n = 188)

n (%)

95% CI for%

Missing values

No clear evidence that PSA testing saves lives

60 (35%)

(27.5, 41.8)

15

PSA testing can lead to unnecessary treatments

28 (17%)

(11.4, 23.2)

26

Treatment for prostate cancer can lead to incontinence

45 (29%)

(22.0, 36.5)

34

Treatment for prostate cancer can lead to erectile dysfunction

53 (33%)

(25.8, 40.5)

28

Most prostate cancers will not affect a man’s health during his lifetime

65 (38%)

(30.5, 45.1)

16